There are numerous conditions, including many rare and difficult to recognize disorders, which can be mistaken for MS, said Andrew Solomon, MD, associate professor of neurological sciences and division chief of multiple sclerosis at Larner College of Medicine, The University of Vermont, Burlington, Vermont.
There are numerous conditions, including many rare and difficult to recognize disorders, which can be mistaken for MS, said Andrew Solomon, MD, associate professor of neurological sciences and division chief of multiple sclerosis at Larner College of Medicine, The University of Vermont, Burlington, Vermont.
Transcript
What are some of the conditions that are commonly misdiagnosed as being MS?
As neurologists, in our training we come to understand that there's this very long list or broad differential diagnosis for MS—there are many disorders, including many rare and difficult to recognize disorders that can be mistaken for MS.
So, while there's many rare and challenging to diagnose disorders that can be mistaken for MS, some of the recent data that we've seen around misdiagnosis and differential diagnosis of MS in referral centers seems to suggest that many common disorders are frequently mistaken for MS. Some of those disorders include things like migraine, small vessel ischemic disease, which is a manifestation often of high blood pressure accompanied by some neurologic symptoms. Functional neurologic disorders may be frequently mistaken for MS, and then there's a number of demyelinating conditions now that we recognize as distinct from MS—neuromyelitis optica spectrum disorder, myelin oligodendrocytes, glycoprotein myelitis, and optic neuritis associated disorders can be easily mistaken for MS.
By virtue of some of these very common disorders being mistaken for MS, it seems like part of the problem is our diagnostic criteria may not be applied in these situations as rigorously as it should. It seems like there may be either misapplication or misunderstanding of different elements of the McDonald criteria that could lead to misdiagnosis of some of these common disorders for MS.
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Distinguishing Biomarkers Identified in MS Outcomes
March 19th 2024Results from this cohort study found that levels of glial fibrillary acid protein, cerebral spinal fluid, and neurofilament heavy chain are distinguishable biomarkers that are associated with disease outcomes in multiple sclerosis (MS).
Read More